ABOUT US
Jiangsu Vanguard Pharmaceutical Co., Ltd.
Jiangsu Vanguard Pharmaceutical Co., Ltd. was established in November 2003 and is located at No. 688 Dinghai Road, Haimen Economic and Technological Development Zone, Jiangsu Province. It is a modern pharmaceutical enterprise integrating drug R&D, production, and sales. The company owns five wholly-owned subsidiaries and six joint ventures, with R&D centers established in Nantong, Nanjing, and Tianjin. It holds production licenses for various dosage forms, including tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops. Its main products cover multiple therapeutic areas, such as cardiovascular diseases, diabetic complications, anti-tumor drugs, calcium supplements, digestive system drugs, respiratory system drugs, and orthopedics. Currently, nine of its products are listed in the National Essential Drug List, 40 are included in the National Reimbursement Drug List, and 30 have passed or are deemed to have passed consistency evaluations. The company also provides CMO/CDMO services, supporting drug R&D, pilot-scale production, and commercial manufacturing.
It has strategically built its R&D pipeline and technical service system around innovative drugs, improved new drugs, and high-end generic medicines, holding 42 invention patents. Recognized as a National High-Tech Enterprise and a Jiangsu Province “Little Giant” Enterprise, Vanguard has been consecutively listed among the “Top 100 Chinese Chemical Drug R&D Powerhouses” at the China Pharmaceutical R&D & Innovation Summit in 2022, 2023, and 2024. In 2024, the company was awarded the title of “Jiangsu Provincial Intelligent Manufacturing Workshop”.
-
2003
YearBusiness Formation
-
96
aCover An Area
-
800
+Number Of Employees
-
42
TermInvention Patent
-
6260
W¥Registered Capital
CORPORATE CULTURE
Corporate Mission
Guided by a human-oriented philosophy and the pursuit of excellence, we are committed to enhancing human quality of life through our products and services. At the same time, our company strives to provide greater value for society, broader career opportunities for employees, and superior returns for shareholders through innovation growth and high profitability, aiming to be a respected pharmaceutical enterprise.
Development Strategy
In terms of Strategic development, we consistently adhere to the principle of "R&D as the guide, production quality as the foundation," focusing on an integrated approach to R&D and production. Regarding product development, we follow a dual-track strategy of "generic drugs + innovative drugs," building a foundation with high-end generics while prioritizing innovative drugs to strengthen our R&D and sales capabilities. Building on the competitive advantages, we will progressively increase R&D investments in high-end generics and innovative drugs, develop products with substantial market potential to enhance our competitiveness and achieve sustainable growth.
2021
2020
2019
2018
2017
2016
Awards & Honors
Top 50 Chinese Chemical Drug R&D Companies in 2024
Top 100 Chinese Pharmaceutical R&D Companies in 2024
Administratively regulated "self-listed" enterprises (2024 Shengzhi Environmental Sector)
Chain Master Recruitment Ambassador Enterprise
Supervisory Unit of Nantong Medical and Health Industry Development Association
Executive Vice President Unit, Nantong Medical and Health Industry Development Association
Top 10 Industrial Enterprises of 2021
2021 Gold Medal Leading Enterprises (Industry)
2020 Innovative Leading Enterprises
Top 100 Industrial Enterprises of 2020
2020 Jiangsu Province Small Giant Enterprises
2019 Key Industrial Enterprises
Top 100 Industrial Enterprises of 2019
2018 High-tech Enterprise
Advanced Enterprises for High-Quality Development in 2018
Top 10 industrial enterprises by economic scale in 2018
Top 10 Enterprises of 2018
Advanced industrial enterprises with significant economic contributions in 2018
Top 100 Industrial Enterprises of 2018
Top 100 Industrial Enterprises of 2017
2016 Gold Medal Enterprise
2016 Gold Award Winning Enterprise
2015 Gold Medal Enterprise
2014 Gold Medal Enterprise
2014 Gold Medal Enterprise
2013 Gold Medal Enterprise
Silver medal enterprise
2014 Haimen City Science and Technology Progress Award
2014 Haimen City Science and Technology Progress Award
Advanced unit
Demonstration Enterprises
Practice Education Base
Certificate of Merit
Certificate of Merit
Demonstration Base for Entrepreneurship by Professional and Technical Personnel of Enterprises
Nantong Municipal Enterprise Technology Center
Nantong Engineering Technology Research Center
Nantong City Demonstration Enterprise of Production, Education and Research
Major taxpayers in the development zone in 2011
2012 Taxpayers in the Development Zone
江苏省质量信得过企业
Jiangsu Province Quality Trustworthy Enterprise
Jiangsu Province-recognized Enterprise Technology Center
高新技术企业
2013 Haimen City Science and Technology Progress Award
2011 Haimen City Science and Technology Progress Award
Standardization Certification
Pilot enterprise certificate
Team Spirit
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Employee Profiles
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.